Does propranolol have a role in cancer treatment? A systematic review of the epidemiological and clinical trial literature on beta-blockers
Journal of Cancer Research and Clinical Oncology · 12.07.2025 · 151 (7)
DOI: 10.1007/s00432-025-06262-2 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Cancer Research and Clinical Oncology, online erschienen am 12.07.2025. Verfasst von Jessica O'Logbon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Guy's and St. Thomas' NHS Trust, St Thomas' Hospital, Westminster Bridge Rd, London, SE1 7EH, UK. j.ologbon@nhs.net. Hauptthemen laut MEDLINE: Propranolol, Adrenergic beta-Antagonists, Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Beta-blockers, originally developed for cardiovascular conditions, have been explored for their potential role in cancer treatment. Propranolol, a non-selective beta-blocker, has shown promise in inhibiting stress-induced signalling pathways associated with cancer progression. This systematic review aims to assess the evidence for the repurposing of propranolol as a treatment for various cancers, particularly breast cancer to answer the research question: Does propranolol improve cancer outcomes, including survival and recurrence?
Methods
We conducted a systematic search of MEDLINE, EMBASE, Global Health, Web of Science, and the Cochrane Library, including studies up to July 2024. Randomised Controlled Trials (RCTs), systematic reviews, and meta-analyses were included if they assessed the effects of propranolol on cancer outcomes such as mortality, survival, recurrence, or biomarkers of tumour regression. A narrative synthesis was performed to summarise the findings.
Results
Thirty-one studies were included, consisting of 7 RCTs, 4 systematic reviews and 20 meta-analyses. The evidence suggests that propranolol may improve cancer outcomes, especially when administered perioperatively, by reducing recurrence risk. However, the results remain inconclusive regarding its use in combination with chemotherapy or radiotherapy, as studies showed mixed results. The timing of propranolol administration, alongside its combination with other cancer therapies, appears to be a key factor in its effectiveness.
Conclusion
Propranolol has potential as an adjunctive therapy in cancer treatment, particularly in reducing recurrence risk during the perioperative period. However, further clinical trials are needed to better define its role in cancer therapy, particularly regarding optimal treatment regimens and patient populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guy's and St. Thomas' NHS Trust, St Thomas' Hospital, Westminster Bridge Rd, London, SE1 7EH, UK. j.ologbon@nhs.net.
- GKT School of Medical Education, Guy's Campus, Great Maze Pond London, London, SE1 1UL, UK. j.ologbon@nhs.net.
- Prostate Cancer Research Centre at the Centre for Stem Cell and Regenerative Medicine, 28 Floor Guy's Hospital, King's College London, Great Maze Pond, London, SE1 9RT, UK.
- Division of Surgery & Interventional Science, University College London, 43-45 Foley, London, W1W 7TY, UK.
- GKT School of Medical Education, Guy's Campus, Great Maze Pond London, London, SE1 1UL, UK.
- Oncolodyne Ltd., Rockefeller Building, University College London, 21 University Street, London, WC1E 6DE, UK.
Zitieren
APA
O'Logbon, J., Tarantola, L., Williams, N. R., Mehta, S., Ahmed, A., & Davies, E. A. (2025). Does propranolol have a role in cancer treatment? A systematic review of the epidemiological and clinical trial literature on beta-blockers. Journal of Cancer Research and Clinical Oncology, 151(7). https://doi.org/10.1007/s00432-025-06262-2
Vancouver
O'Logbon J, Tarantola L, Williams NR, Mehta S, Ahmed A, Davies EA. Does propranolol have a role in cancer treatment? A systematic review of the epidemiological and clinical trial literature on beta-blockers. Journal of Cancer Research and Clinical Oncology. 2025;151(7). doi:10.1007/s00432-025-06262-2
BibTeX
@article{OLogbon2025,
author = {O'Logbon, Jessica and Tarantola, Ludovica and Williams, Norman R and Mehta, Shreeya and Ahmed, Aamir and Davies, Elizabeth A},
title = {Does propranolol have a role in cancer treatment? A systematic review of the epidemiological and clinical trial literature on beta-blockers},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2025},
volume = {151},
number = {7},
doi = {10.1007/s00432-025-06262-2}
}
EUVIMED